Non-melanoma skin cancer represents one-third of all malignancies and its incidence is
expected to rise until the year 2040. Cutaneous squamous cell carcinoma (cSCC) …

Cutaneous squamous cell carcinoma (SCC) ranks second in the frequency of all skin
tumors. Its incidence has risen significantly due to an increased sun exposure and the …

Purpose: A rare 5% of cutaneous squamous cell carcinomas (cSCC) metastasize, lack FDA-
approved therapies, and carry a poor prognosis. Our aim was to identify recurrent genomic …

Eyelid cancers account for 5% to 10% of all cutaneous malignancies. The incidence of
eyelid cancer is approximately 15 cases per 100,000 individuals per year. Basal cell …

The epidermal growth factor (EGF) family of receptor tyrosine kinases consists of four
members: EGFR (HER1/ErbB1), HER2/neu (ErbB2), HER3 (ErbB3) and HER4 (ErbB4) …

Background Cutaneous squamous cell carcinoma (CSCC) is the second most frequent
cancer in humans after basal cell carcinoma, and its incidence is dramatically rising. CSCC …

Cutaneous squamous cell carcinoma (SCC) is an already common disorder with a rapidly
increasing incidence. Treatment of early disease depends primarily on surgery or …

Non-melanoma skin cancer of the head and neck (NMSCHN) is one of the most common
malignancies worldwide, and its incidence is growing at a significant rate. It has been found …

Purpose: To review the literature on targeted therapy for orbital and periocular basal cell
carcinoma (BCC) and cutaneous squamous cell carcinoma (SCC) and provide examples of …

Cutaneous squamous cell carcinoma (SCC) of the head and neck may metastasize in up to
5% of patients, with the parotid lymph nodes the most frequent site for spread. Metastases …